Medical and Pharmaceutical

The health minister says the country has only a third of the October shipment left and more isn't expected until next month

On top of cannabis research, the centre will act as a knowledge exchange between medical institutions in other countries like Canada

But it's unclear how the bill will do in the upper house, and the Bolsonaro administration opposes cannabis use

The company says a majority of new sales growth is coming from its focus on medical cannabis

While pleased with a growing acceptance of cannabis, Anutin Charnvirakul is promising greater access

While there's only limited data on the effects of cannabis in minors, researchers suggest it as an alternative to surgery in severe cases

The company says it will use data from its clinics in Colombia and Peru to help treat patients in the UK

Data was collected via the Strainprint app, and is some of the first research of its kind to focus on regulated products

The state's cannabis control board announced legislative changes to increase patient access at a meeting Oct. 5

Regulations have been laid out for weed testing at work and home cultivation for certified medical patients

Supporters of the bill hope it isn't vetoed by the president

It’s the first federal grant to be awarded for psychedelic treatment research in 50 years

In a report by several industry groups, its authors continue to argue for less restriction to battle the still-thriving illicit market

After a spike in demand for research, the DEA is proposing increased quotas for controlled substances including MDMA, LSD, psilocybin and cannabis

All the bills seek to regulate a cannabis market, as well as define rules for cannabis social clubs and cultivation

A majority of physicians aren't equipped to talk about medical cannabis, and patients often look for information elsewhere

Taking sublingual oils proved beneficial for chronic pain, nausea, anxiety and a list of other common ailments

A loss of $2.6M this quarter represents a 58% drop

The firm says expenses will increase as research and 'important progress' continues

A number of the medical cannabis maker's products are available to Canadian patients

Pathway Health is helping pharmacies prepare in anticipation of changes to Canada's pot laws

The agencies are trying to crack down on the alternative cannabinoid after a surge in availability and adverse events this year

The Cross-Party Group on Medical Cannabis hopes to shed light on developing treatments

The research relied on an inaccurate timeframe and didn't distinguish between legal and illegal products, critics say

Recreational sales make up the bulk of transactions, but patients stick to the medical system for a number of reasons

The five-year deal allows the company to access 85% operational capacity of a Queensland facility

The agency says it supports research into the substances and it's necessary for the FDA to approve new quotas

Two high-CBD formulations will be tested for their ability to improve sleep in people suffering from major depressive disorder

Bill 153 is one signature away from taking effect

According to Canadian researchers, cannabis can help people cut the country's most fatal dependency

A 5-year project led by university researchers will study pot as a treatment for opioid use and dependency on methadone or suboxone

Companies are trying to profit off of misinformation, says Evergreen Cannabis co-owner Mike Babins

The partnership will allow Materia to meet the rapidly growing demand for medical extracts in Germany, company says

Legal cannabis is projected to bring in $165 million in revenue annually for Wisconsin along with sustainable jobs

When asked why patient requests for legal psilocybin are being denied or delayed, the agency said studies are the best route for access

Only registered patients can form associations able to get a licence to grow, process, transport and store weed for medical purposes

The funding will be given to one party to determine the effectiveness of cannabis in children with epilepsy

Avihu Tamir explains why his company is set to lead the pack in one of the world's fastest-expanding pot economies

TheraPsil's CEO expects change for psilocybin to come in a matter of months because of the work done for cannabis